In December 2019, a cluster of pneumonia caused by a novel coronavirus (2019-nCoV),
officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Intensive care unit (ICU) admissions and mortality in severe COVID-19 patients are driven
by “cytokine storms” and acute respiratory distress syndrome (ARDS). Interim clinical trial …

Abstract Coronavirus disease 2019 (COVID-19) is the disease caused by the highly
transmittable novel coronavirus (SARS-CoV-2) infections. The disease was found at the end …

The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to …

Recently, the novel coronavirus disease (COVID-19) has broken out worldwide, 1 with rapid
increase of infected patients. COVID-19 dominantly leads to pneumonia. 2 Among these …

The outbreak of COVID-19 reminds us that the emerging and reemerging respiratory virus
infections pose a continuing threat to human life. Cytokine storm syndromes of viral origin …

Since December 2019, Corona Virus Disease 2019 (COVID-19) cases have occurred in
Wuhan, Hubei. 1 The epidemic spread rapidly to other regions outside of China and had a …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger a cytokine
storm in the pulmonary tissue by releasing various types of mediators, leading to acute …

COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …

Acute respiratory distress syndrome (ARDS) and robust cytokine storm are the hallmark of
severe COVID-19 cases. Using single-cell RNA sequencing of bronchoalveolar lavage fluid …